Reference health

Descriptive epidemiology of sarcomas in Europe: Report from the RARECARE project

https://doi.org/10.1016/j.ejca.2012.09.011
CiteStamped reference-health badge
30/30 checkable references clean · checked 2026-07-23

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

1 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 30 checked references that resolve
resolves10.1002/ijc.22239
Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978–2001: An analysis of 26,758 cases
resolves10.1016/j.ejca.2008.11.018
EUROCARE-4. Survival of cancer patients diagnosed in 1995–1999. Results and commentary
resolves10.1038/nrc1168
Mechanisms of sarcoma development
resolves10.1002/cncr.24121
Osteosarcoma incidence and survival rates from 1973 to 2004
resolves10.1093/annonc/mdf152
Measuring cancer prevalence in Europe: the EUROPREVAL Project
resolves10.1002/(SICI)1097-0258(19970228)16:4<425::AID-SIM414>3.0.CO;2-Z
ESTIMATING THE COMPLETENESS OF PREVALENCE BASED ON CANCER REGISTRY DATA
resolves10.2307/2529873
Cancer Survival Corrected for Heterogeneity in Patient Withdrawal
resolves10.1002/(SICI)1097-0142(19961101)78:9<2004::AID-CNCR23>3.0.CO;2-#
An alternative approach to monitoring cancer patient survival
resolves10.1002/(SICI)1097-0258(19990228)18:4<441::AID-SIM23>3.0.CO;2-M
Mixture models for cancer survival analysis: application to population-based data with covariates
resolves10.1016/j.ejca.2003.11.009
Current soft-tissue sarcoma classifications
resolves10.1002/ijc.24320
International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons
resolves10.1158/1055-9965.EPI-11-0136
Age-Period-Cohort Analysis of Primary Bone Cancer Incidence Rates in the United States (1976–2005)
resolves10.1016/j.ctrv.2010.11.003
A decade of tyrosine kinase inhibitor therapy: Historical and current perspectives on targeted therapy for GIST
resolves10.1002/cncr.20862
Gastrointestinal stromal tumors: The incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era
resolves10.1016/j.ejca.2005.09.009
Incidence of gastrointestinal stromal tumours is underestimated: Results of a nation-wide study
resolves10.1002/ijc.21167
Gastrointestinal stromal tumors in Iceland, 1990–2003: The Icelandic GIST study, a population‐based incidence and pathologic risk stratification study
resolves10.1016/j.ejca.2006.07.015
Population-based incidence and survival of gastrointestinal stromal tumours (GIST) in Girona, Spain
resolves10.1186/1471-2407-7-230
Incidence and clinicopathologic features of gastrointestinal stromal tumors. A population-based study
resolves10.1002/pbc.23252
Soft tissue sarcoma across the age spectrum: A population‐based study from the surveillance epidemiology and end results database
resolves10.2106/JBJS.H.00416
Chondrosarcoma in the United States (1973 to 2003): An Analysis of 2890 Cases from the SEER Database
resolves10.1016/S0959-8049(98)00335-9
Survival of adult patients with cancer of soft tissues or bone in Europe
resolves10.1016/S0959-8049(01)00004-1
Survival of children with bone sarcoma in Europe since 1978
resolves10.1016/j.ejca.2006.05.015
Bone tumours in European children and adolescents, 1978–1997. Report from the Automated Childhood Cancer Information System project
resolves10.1093/annonc/mdh058
Conformity to clinical practice guidelines, multidisciplinary management and outcome of treatment for soft tissue sarcomas
resolves10.1080/13577140410001679185
Should Soft Tissue Sarcomas be Treated at a Specialist Centre?
resolves10.1038/sj.bjc.6602885
Patterns of care and survival for patients aged under 40 years with bone sarcoma in Britain, 1980–1994
resolves10.1097/01.sla.0000250438.04393.a8
Should Soft Tissue Sarcomas Be Treated at High-volume Centers?
resolves10.1038/sj.bjc.6604527
Endometrial stromal sarcoma: a population-based analysis
resolves10.1200/JCO.2011.35.3656
Phase II Study of Imatinib in Advanced Chordoma
resolves10.1093/annonc/mdq644
Sunitinib in advanced alveolar soft part sarcoma: evidence of a direct antitumor effect
The 1 reference without a DOI — listed, not checked
no DOI — not checkedConcise handbook of familial cancer susceptibility syndromes. Second edition
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1016/j.ejca.2012.09.011"><img src="https://citestamp.com/citestamped/10.1016/j.ejca.2012.09.011/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1016/j.ejca.2012.09.011/badge.svg)](https://citestamp.com/citestamped/10.1016/j.ejca.2012.09.011)